Varenyam Biolifesciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 29-10-2024
- Paid Up Capital ₹ 4.50 Cr
as on 29-10-2024
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Varenyam Biolifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bharatkumar Desai, Bhahim Desai, and Keval Shah serve as directors at the Company.
- CIN/LLPIN
U24290GJ2022PTC133332
- Company No.
133332
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2022
- Date of AGM
09 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Varenyam Biolifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharatkumar Desai  | Director | 28-Jun-2022 | Current |
| Bhahim Desai | Director | 28-Jun-2022 | Current |
| Keval Shah | Director | 28-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Varenyam Biolifesciences.
Varenyam Biolifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Varenyam Biolifesciences?
In 2023, Varenyam Biolifesciences had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Varenyam Healthcare Private LimitedActive 8 years 5 monthsBhahim Desai and Keval Shah are mutual person
Innoxel Lifesciences Private LimitedActive 4 years 2 monthsBharatkumar Desai and Bhahim Desai are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Varenyam Biolifesciences?
Varenyam Biolifesciences has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Varenyam Biolifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Varenyam Biolifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
